Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects


The potential antagonism of a single oral dose of RU 41 656 (10 mg) on the memory and attention disturbances induced by oral administration of triazolam (0.25 mg) have been investigated in a 3-period, placebo controlled, double blind, cross-over study involving 12 healthy young volunteers. The effects of the compounds were evaluated by objective tests… (More)
DOI: 10.1007/BF02244557


6 Figures and Tables

Slides referencing similar topics